Article: Once Daily Fondaparinux Found as Effective and Safe as Unfractionated Heparin In the Initial Treatment of Symptomatic Pulmonary Embolism; Published Report of MATISSE PE Study in the New England Journal of Medicine Sets Stage for Improved Management of Patients Suffering From the Condition.

Article: TMS offers on-line PE study guide
JOM;  December 1, 1999 ;     551 words ... ... licensing exam to become a registered professional engineer in the United States can now take advantage of the TMS on-line PE study guide at www.tms.org/Education/PE /PE.html. The study aid, the fourth prepared by the TMS Professional Registration ...

Article: IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) ...
PR Newswire;  February 4, 2008 ;     700+ words ...Children's Oncology Group Report Shows the Addition of L-MTP-PE to Chemotherapy Reduced the Risk of Death by 30% in Osteosarcoma Patients IRVINE, Calif., Feb. 4 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. today announced the Journal of Clinical Oncology (JCO) has published findings from the Phase 3

Article: Once-daily subcutaneous treatment effective for symptomatic ...
Biotech Business Week;  November 24, 2003 ;     700+ words ... ... embolism (PE), according to the MATISSE PE study published in the New England ... antithrombotic therapy, the MATISSE PE study shows that pulmonary embolism ... the steering committee for the MATISSE PE study. The MATISSE PE study is the ...

Article: Arixtra (Fondaparinux Sodium) Once Daily Demonstrates Benefit in ...
PR Newswire;  December 9, 2002 ;     700+ words ... ... MATISSE trials were conducted, MATISSE PE and MATISSE DVT. The randomised ... adjudication committee. In the MATISSE PE study, 2,213 patients presenting ... DVT study and 15 percent in the MATISSE PE study. The two studies demonstrate ...

Article: Arixtra demonstrates benefit in MATISSE studies.
Biotech Week;  February 12, 2003 ;     700+ words ... ... MATISSE trials were conducted, MATISSE PE and MATISSE DVT. The randomized ... adjudication committee. In the MATISSE PE study, 2,213 patients presenting ... MATISSE DVT study and 15% in the MATISSE PE study. The two studies demonstrate ...

Article: New Indications for Arixtra(R) in the United States: The ...
PR Newswire;  June 4, 2004 ;     700+ words ... ... clinical dossier was based upon the findings of the MATISSE PE and MATISSE DVT studies which demonstrated that a new ... introduction of unfractionated heparin (UFH). The MATISSE PE study is the largest worldwide trial ever performed in the ...

Article: New Arixtra indications: Acute deep venous thrombosis, acute ...
Biotech Week;  June 30, 2004 ;     511 words ... ... indications for Arixtra was submitted to the FDA July 31, 2003. The clinical dossier was based upon the findings of the MATISSE PE and MATISSE DVT studies which demonstrated that a new strength of Arixtra 7.5 mg given as a once daily subcutaneous injection ...